GC Genome Corporation (KOSDAQ:340450)

GC Genome Revenue

GC Genome had revenue of 7.44B KRW in the quarter ending March 31, 2026, with 9.13% growth. This brings the company's revenue in the last twelve months to 32.16B, up 19.32% year-over-year. In the year 2025, GC Genome had annual revenue of 31.53B with 21.81% growth.

• Revenue (ttm): 32.16B
• Revenue Growth: +19.32%
• P/S Ratio: 3.74
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 120.15B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	31.53B	5.65B	21.81%
Dec 31, 2024	25.89B	-1.40B	-5.15%
Dec 31, 2023	27.29B	3.18B	13.18%
Dec 31, 2022	24.11B	5.62B	30.36%
Dec 31, 2021	18.50B	4.94B	36.46%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 8, 2026

Data Sources Report a data error